Literature DB >> 33617515

Evolution of Public Health Human Papillomavirus Immunization Programs in Canada.

Alexandra Goyette1, Glorian P Yen2, Voica Racovitan1, Parambir Bhangu1, Smita Kothari2, Eduardo L Franco3.   

Abstract

Background: Since 2007, all Canadian provinces and territories have had a publicly funded program for vaccination against human papillomavirus (HPV) infection. The objective of this study was to describe the evolution of these vaccination programs.
Methods: This was a targeted literature review of public HPV vaccination programs and vaccination coverage rates, based on information provided by jurisdictional public health authorities.
Results: HPV vaccination of schoolgirls began in school years 2007/08 to 2010/11 with three doses of the quadrivalent HPV vaccine in all provinces except Quebec, which started with two doses. By 2018/19, all jurisdictions were vaccinating with two doses of the nonavalent vaccine in both girls and boys, except Quebec, which used a mixed vaccination schedule with one dose of the nonavalent and one dose of the bivalent vaccines. Public HPV vaccination programs in most provinces include after-school catch-up vaccination. Immunocompromised or other high-risk individuals are eligible for the HPV public vaccination program in most provinces, but policies vary by jurisdiction. In 2017/18, vaccination coverage rates in provincial HPV school-based programs varied from 62% in Ontario to 86% in Prince Edward Island in girls and from 58% in Ontario to 86% in Prince Edward Island in boys. Conclusions: Since their introduction, Canadian school-based HPV public vaccination programs have evolved from a three-dose to a two-dose schedule, from a quadrivalent to a nonavalent vaccine, and from a girls-only to a gender-neutral policy. Vaccination coverage rates have varied markedly and only Prince Edward Island and Newfoundland/Labrador have maintained rates exceeding 80%.

Entities:  

Keywords:  Canada; human papillomavirus; public health programs; school health services; vaccination; vaccine policy

Year:  2021        PMID: 33617515      PMCID: PMC7985769          DOI: 10.3390/curroncol28010097

Source DB:  PubMed          Journal:  Curr Oncol        ISSN: 1198-0052            Impact factor:   3.677


  23 in total

1.  A review of human carcinogens--Part B: biological agents.

Authors:  Véronique Bouvard; Robert Baan; Kurt Straif; Yann Grosse; Béatrice Secretan; Fatiha El Ghissassi; Lamia Benbrahim-Tallaa; Neela Guha; Crystal Freeman; Laurent Galichet; Vincent Cogliano
Journal:  Lancet Oncol       Date:  2009-04       Impact factor: 41.316

2.  A mixed two-dose vaccination schedule: Not enough evidence to support a policy change in Quebec.

Authors:  Zeev Rosberger; Marc Steben; Teresa Norris; Amelie McFadyen; Gilla K Shapiro
Journal:  Vaccine       Date:  2019-07-26       Impact factor: 3.641

3.  Using the precaution adoption process model to clarify human papillomavirus vaccine hesitancy in canadian parents of girls and parents of boys.

Authors:  Ovidiu Tatar; Gilla K Shapiro; Samara Perez; Kristina Wade; Zeev Rosberger
Journal:  Hum Vaccin Immunother       Date:  2019-04-22       Impact factor: 3.452

Review 4.  A Review of the Impact and Effectiveness of the Quadrivalent Human Papillomavirus Vaccine: 10 Years of Clinical Experience in Canada.

Authors:  Marc Steben; Mattea Tan Thompson; Caroline Rodier; Nathalie Mallette; Voica Racovitan; Fern DeAngelis; Melissa Stutz; Emmanouil Rampakakis
Journal:  J Obstet Gynaecol Can       Date:  2018-10-16

Review 5.  Human papillomavirus and cervical cancer.

Authors:  Eileen M Burd
Journal:  Clin Microbiol Rev       Date:  2003-01       Impact factor: 26.132

Review 6.  Human papillomavirus vaccine introduction--the first five years.

Authors:  Lauri E Markowitz; Vivien Tsu; Shelley L Deeks; Heather Cubie; Susan A Wang; Andrea S Vicari; Julia M L Brotherton
Journal:  Vaccine       Date:  2012-11-20       Impact factor: 3.641

7.  Psychosocial determinants of parental human papillomavirus (HPV) vaccine decision-making for sons: Methodological challenges and initial results of a pan-Canadian longitudinal study.

Authors:  Samara Perez; Ovidiu Tatar; Gilla K Shapiro; Eve Dubé; Gina Ogilvie; Juliet Guichon; Vladimir Gilca; Zeev Rosberger
Journal:  BMC Public Health       Date:  2016-12-05       Impact factor: 3.295

Review 8.  Human papillomavirus vaccination: the population impact.

Authors:  Lai-Yang Lee; Suzanne M Garland
Journal:  F1000Res       Date:  2017-06-12

9.  Surveillance of Vaccination Coverage among Adult Populations - United States, 2015.

Authors:  Walter W Williams; Peng-Jun Lu; Alissa O'Halloran; David K Kim; Lisa A Grohskopf; Tamara Pilishvili; Tami H Skoff; Noele P Nelson; Rafael Harpaz; Lauri E Markowitz; Alfonso Rodriguez-Lainz; Amy Parker Fiebelkorn
Journal:  MMWR Surveill Summ       Date:  2017-05-05

10.  Estimates and determinants of HPV non-vaccination and vaccine refusal in girls 12 to 14 y of age in Canada: Results from the Childhood National Immunization Coverage Survey, 2013.

Authors:  Nicolas L Gilbert; Heather Gilmour; Ève Dubé; Sarah E Wilson; Julie Laroche
Journal:  Hum Vaccin Immunother       Date:  2016-03-04       Impact factor: 3.452

View more
  1 in total

Review 1.  The Path to Eliminating Cervical Cancer in Canada: Past, Present and Future Directions.

Authors:  Hannah Caird; Jonathan Simkin; Laurie Smith; Dirk Van Niekerk; Gina Ogilvie
Journal:  Curr Oncol       Date:  2022-02-14       Impact factor: 3.677

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.